Evolution of deceased-donor transplantation in India with decline of commercial transplantation: a lesson for developing countries

Kidney International Supplements

Volumn 3, Issue 2, 2013, Pages 190-194

  Abraham, Georgi ^a   Reddy, Yuvaram N V ^a   Reddy, Yogesh N V ^a   Shroff, Sunil ^a   Mathew, Milly ^a   Saravanan, Sundarajan ^a  

^a MADRAS MEDICAL MISSION HOSPITAL   (India)

Author keywords

chronic kidney disease; commercialization; deceased donor transplantation; developing countries

Indexed keywords

EID: 85007257901     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2013.12     Document Type: Article

References (10)

1. Modi, G.K., Jha, V., The incidence of end-stage renal disease in India: a population-based study. Kidney Int 70 (2006), 2131–2133.
2. Abraham, G., Shroff, S., Nayak, K.S., et al. Deceased donor renal transplantation program in India. Kidney Int 77 (2010), 378–380.
3. Abraham, G., John, G.T., Shroff, S., et al. Evolution of renal transplantation in India over the last four decades. NDT plus 3 (2010), 203–207.
4. Abraham, G., The challenges of renal replacement therapy in Asia. Nat Clin Pract Nephrol, 4, 2008, 643.
5. Khanna, P., The economics of dialysis in India. Indian J Nephrol 19 (2009), 1–4.
6. Health Division, Report on the Steering Committee of Health for the 12th Five Year Plan. Planning Commission of India, 2012, 643.
7. Ali, A.A.M., Khanna, P., Mathew, M., et al. Can single dose induction regimen with IL-2R monoclonal antibodies improve long term renal function over multiple doses in Indian renal transplant recipients?. JNRT 2 (2009), 146–158.
8. Sidhu, M.S., Nayak, K.S., Subramanyan, S.V., et al. Polyclonal antibodies in renal transplantation—a relook. Transplant Proc 39 (2007), 766–772.
9. Sundaram, V., Abraham, G., Fathima, N., et al. Management of chronic allograft injury with Rapamycin-Saudi. J Kidney Dis Transplant 21 (2010), 37–42.
10. Guduru, S.L., Abraham, G., et al. Diagnostic efficacy of C4d immunostaining in the detection of the humoral component of renal allograft rejection and therapeutic implications. Indian J Pathol Microbiol 52 (2009), 345–348.